Profiles

Keywords
Last Name
Institution

Marta Batus

Concepts (115)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
8
2016
296
2.320
Why?
Carcinoma, Non-Small-Cell Lung
12
2018
352
1.700
Why?
Lung Neoplasms
12
2018
717
1.410
Why?
Molecular Targeted Therapy
3
2013
38
1.210
Why?
Antibodies, Monoclonal
4
2016
305
0.970
Why?
Sarcoma
3
2019
92
0.870
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2019
378
0.820
Why?
Immunotherapy
2
2013
67
0.720
Why?
Medical Oncology
1
2016
37
0.720
Why?
Chemoradiotherapy
4
2019
70
0.670
Why?
ErbB Receptors
4
2018
76
0.590
Why?
Melanoma
1
2013
60
0.570
Why?
Bone Neoplasms
1
2013
107
0.540
Why?
Carcinoma, Squamous Cell
4
2018
188
0.360
Why?
Drug Resistance, Neoplasm
2
2018
69
0.320
Why?
Neoplasm Recurrence, Local
2
2016
181
0.310
Why?
Receptor, IGF Type 1
2
2013
18
0.290
Why?
Quinazolines
2
2012
27
0.270
Why?
Humans
20
2019
26729
0.270
Why?
Prognosis
6
2018
920
0.270
Why?
Neoplasm Staging
7
2016
479
0.240
Why?
Adenocarcinoma
3
2018
227
0.230
Why?
Retrospective Studies
10
2019
2780
0.230
Why?
Inflammation Mediators
1
2018
81
0.200
Why?
Palliative Care
2
2015
104
0.190
Why?
Female
15
2019
15965
0.190
Why?
Treatment Outcome
7
2019
3364
0.190
Why?
Male
14
2019
15601
0.190
Why?
Gene Dosage
2
2012
27
0.170
Why?
Protein Kinase Inhibitors
2
2018
61
0.170
Why?
Neoplasm Metastasis
2
2013
138
0.170
Why?
Aged
10
2019
8906
0.160
Why?
Survival Rate
4
2018
418
0.160
Why?
Radiotherapy, Conformal
1
2014
24
0.150
Why?
Cancer Vaccines
1
2013
19
0.150
Why?
Angiogenesis Inhibitors
1
2013
25
0.150
Why?
Neoplasms
1
2016
236
0.150
Why?
Mutation
2
2018
409
0.150
Why?
Forecasting
1
2013
128
0.140
Why?
Adult
6
2019
8754
0.140
Why?
Weight Gain
1
2012
59
0.140
Why?
Middle Aged
10
2019
10097
0.140
Why?
Follow-Up Studies
5
2018
1872
0.140
Why?
PTEN Phosphohydrolase
1
2011
13
0.140
Why?
Phosphatidylinositol 3-Kinases
1
2011
48
0.130
Why?
Survival Analysis
4
2015
372
0.130
Why?
Gene Amplification
1
2010
28
0.130
Why?
Child, Preschool
1
2013
752
0.120
Why?
Xanthine Dehydrogenase
1
2010
7
0.120
Why?
Pyrimidines
1
2010
27
0.120
Why?
Gastrointestinal Stromal Tumors
1
2010
12
0.120
Why?
Rectal Neoplasms
1
2010
26
0.120
Why?
Young Adult
2
2016
1937
0.120
Why?
Adolescent
2
2016
2397
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2010
117
0.120
Why?
Piperazines
1
2010
87
0.110
Why?
United States
1
2016
2104
0.110
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
6
0.110
Why?
Child
1
2013
1393
0.110
Why?
Clinical Trials as Topic
1
2010
370
0.110
Why?
Chromosomes, Human, Pair 10
1
2007
6
0.100
Why?
Chromosomes, Human, Pair 3
1
2007
7
0.100
Why?
Chromosomes, Human, Pair 1
1
2007
13
0.100
Why?
Receptor, ErbB-2
1
2007
40
0.100
Why?
Carcinoma, Large Cell
2
2018
18
0.090
Why?
Animals
2
2013
4851
0.090
Why?
Neoadjuvant Therapy
2
2019
62
0.080
Why?
Kaplan-Meier Estimate
2
2017
203
0.080
Why?
Carboplatin
2
2015
48
0.080
Why?
Etoposide
2
2015
64
0.080
Why?
Paclitaxel
2
2015
73
0.080
Why?
Aged, 80 and over
4
2018
4537
0.070
Why?
Breast Neoplasms
1
2007
404
0.070
Why?
Cohort Studies
2
2015
1650
0.060
Why?
Mesna
1
2019
4
0.060
Why?
Ifosfamide
1
2019
16
0.060
Why?
Organ Sparing Treatments
1
2019
12
0.050
Why?
Arm
1
2019
51
0.050
Why?
Doxorubicin
1
2019
74
0.050
Why?
Leg
1
2019
46
0.050
Why?
Proteomics
1
2018
47
0.050
Why?
Leukocyte Count
1
2017
90
0.050
Why?
Taxoids
1
2016
16
0.050
Why?
Tomography, X-Ray Computed
2
2014
823
0.050
Why?
Lymphocytes
1
2017
107
0.050
Why?
Deoxycytidine
1
2016
46
0.050
Why?
Body Weight
1
2017
156
0.050
Why?
Radiation Pneumonitis
1
2015
4
0.050
Why?
Hemoptysis
1
2015
9
0.050
Why?
Esophagitis
1
2015
11
0.040
Why?
Cough
1
2015
12
0.040
Why?
Neutrophils
1
2017
125
0.040
Why?
Chest Pain
1
2015
20
0.040
Why?
Dyspnea
1
2015
25
0.040
Why?
Chemoradiotherapy, Adjuvant
1
2015
20
0.040
Why?
Radiation Injuries
1
2015
41
0.040
Why?
Disease-Free Survival
1
2015
230
0.040
Why?
Mobility Limitation
1
2015
81
0.040
Why?
Radiotherapy Dosage
1
2014
145
0.040
Why?
Diet
1
2015
169
0.040
Why?
Radiotherapy Planning, Computer-Assisted
1
2014
73
0.040
Why?
Prospective Studies
1
2018
1590
0.040
Why?
Class I Phosphatidylinositol 3-Kinases
1
2011
10
0.030
Why?
Activities of Daily Living
1
2015
418
0.030
Why?
Benzamides
1
2010
11
0.030
Why?
Immunohistochemistry
1
2012
478
0.030
Why?
Colectomy
1
2010
33
0.030
Why?
Quality of Life
1
2015
534
0.030
Why?
Combined Modality Therapy
1
2011
453
0.030
Why?
Biopsy
1
2010
267
0.030
Why?
Smoking
1
2010
170
0.030
Why?
Signal Transduction
1
2012
524
0.030
Why?
Fatal Outcome
1
2008
71
0.030
Why?
Risk Assessment
1
2011
719
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2007
118
0.020
Why?
Batus's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description